Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]

A US National Institutes of Health grant will fund an [...]

Resolution Therapeutics has partnered with Blood Centers of America to [...]

Eleva is separating its moss-based biologics platform from its clinical-stage [...]

AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]

Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

A survey of more than 50 senior pharmaceutical and biotechnology [...]

Tagomics has launched a cell-free DNA platform designed to monitor [...]